Description of the ARMADA (assessing reliable measurement in Alzheimer’s disease) general population study cohorts
dc.contributor.author | Karpouzian-Rogers, Tatiana | |
dc.contributor.author | Ho, Emily | |
dc.contributor.author | Novack, Miriam | |
dc.contributor.author | Chinkers, Miriam | |
dc.contributor.author | Wortman, Katy | |
dc.contributor.author | Nowinski, Cindy J. | |
dc.contributor.author | Dodge, Hiroko H | |
dc.contributor.author | Giordani, Bruno | |
dc.contributor.author | Gershon, Richard C. | |
dc.contributor.author | Weintraub, Sandra | |
dc.date.accessioned | 2023-07-14T13:56:22Z | |
dc.date.available | 2024-07-14 09:56:22 | en |
dc.date.available | 2023-07-14T13:56:22Z | |
dc.date.issued | 2023-06 | |
dc.identifier.citation | Karpouzian-Rogers, Tatiana ; Ho, Emily; Novack, Miriam; Chinkers, Miriam; Wortman, Katy; Nowinski, Cindy J.; Dodge, Hiroko H; Giordani, Bruno; Gershon, Richard C.; Weintraub, Sandra (2023). "Description of the ARMADA (assessing reliable measurement in Alzheimer- s disease) general population study cohorts." Alzheimer’s & Dementia 19: n/a-n/a. | |
dc.identifier.issn | 1552-5260 | |
dc.identifier.issn | 1552-5279 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/177247 | |
dc.description.abstract | BackgroundGiven the growing population of aging adults, and subsequently individuals with dementia, there is a need for instruments that can detect cognitive impairment in early stages. The NIH Toolbox® for Assessment of Neurological and Behavioral Function (NIHTB) is a computerized battery of assessments measuring multiple domains cognition, emotion, sensation, and motor abilities. The goal of the ARMADA study is to validate the NIHTB in individuals with mild cognitive impairment (MCI) and dementia of the Alzheimer type (DAT). Here, we describe the demographic and clinical characteristics of participants ages 65 to 85 from the general population sample.MethodNormal control (NC), MCI, and DAT groups racially proportional to the US population were recruited from existing cohorts across nine Alzheimer’s Disease Research Centers and sites with cognitive aging studies. Diagnoses were based on the Uniform Data Set methodology, and included multiple clinical and cognitive assessments. Participants completed the NIH Toolbox at baseline, 12-, and 24-month visits.ResultGroups were matched with respect to multiple demographic characteristics. There were some differences in age and sex, such that the NC group had more female participants and was the youngest. Dementia severity levels differed as expected, with the DAT group demonstrating greater cognitive and functional impairment compared to the MCI group, and the NC group demonstrating minimal cognitive or functional symptoms. Additionally, the DAT group reported more neuropsychiatric symptoms compared to the NC and MCI groups. There was no difference in reported family history of cognitive impairment across groups. Many participants across groups had at least one Alzheimer biomarker collected.ConclusionThe study cohorts included in the ARMADA study accurately reflect their respective clinical syndromes for validating the NIHTB across the cognitive aging spectrum. The goals for the ARMADA study include comparing performance on all four modules of the NIHTB across groups, evaluating the relationship between Alzheimer biomarkers and NIHTB measures, and measuring changes in performance longitudinally. Special emphasis groups, including individuals over age 85, African American participants, and Spanish-Speaking participants, were also recruited and are reported elsewhere. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Description of the ARMADA (assessing reliable measurement in Alzheimer’s disease) general population study cohorts | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Neurology and Neurosciences | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/177247/1/alz068172.pdf | |
dc.identifier.doi | 10.1002/alz.068172 | |
dc.identifier.source | Alzheimer’s & Dementia | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.